There was theory a week ago that the U.S. Drug Enforcement Administration may be nearly downgrading the Schedule I characterization of marijuana. Sadly, the finished result demonstrated the suggestions behind the gossipy tidbits were to some degree exaggerated, as the administration moved to ease the restrictions encompassing the crop’s notorious THC with a goal to help the study process for Big Pharma.
Last Wednesday, Tom Angell with the Marijuana Majority uncovered that he had received a letter from Congressman Earl Blumenauer that insinuated that the Food and Drug Administration and DEA were finally cooperating to reschedule weed under federal law. In spite of the fact that the details were minute, the record, which was sent to Blumenauer by the Justice Department, unmistakably expresses that the “DEA is currently reviewing two petitions to reschedule marijuana in accordance with the [Controlled Substances Act].”
The news of this advancement created a lot of joy in pot advocates throughout the country. The agreement was that paying little mind to how little the change if the government did at last choose to change the Schedule I status of the drug, it would be a major stride in the right place. A piece published in SF Weekly proposed, “The drug is in a good position in Schedule I” because “there’s nowhere to go but down.”
Pot’s present Schedule I classification puts it amongst the most perilous drugs on the planet, halting the plant from getting to be recognized at the national level as a powerful medicine for a vast number of conditions. Thusly, the reality of the matter is that a basic rescheduling to a Schedule II, which would characterize the herb as having some therapeutic worth, would open up incalculable doors for the cannabis plant to thrive in the medicinal area. In any case, pot advocates did not stop to consider that the proposed rescheduling as of late set forth by the government was just a first to help the “reptiles” of the pharmaceutical field.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
